ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

WINTW Windtree Therapeutics Inc (PK)

0.0009
0.00 (0.00%)
May 06 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0.00
Bid Price 0.0009
Ask Price 0.007
News -
Share Name Share Symbol Market Stock Type
Windtree Therapeutics Inc (PK) WINTW OTCMarkets Equity Warrant
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.0009 08:30:26
Open Price Low Price High Price Close Price Previous Close
0.0009 0.0009
Trades Shares Traded Average Volume
0 0.00 -
Last Trade Type Quantity Price Currency
- 0  0.0009 USD

Windtree Therapeutics Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
25.07M 4.78M - 0 -20.29M -3.94 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Windtree Therapeutics (PK)

Real-Time news about Windtree Therapeutics Inc (PK) (OTCMarkets): 0 recent articles
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No WINTW Message Board. Create One! See More Posts on WINTW Message Board See More Message Board Posts

WINTW Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

A clinical-stage biopharmaceutical and device company focused on developing novel therapies for acute cardiovascular and pulmonary diseases. Windtree's lead product candidates are being developed to treat acute heart failure and respiratory distress syndrome in premature infants.

Your Recent History

Delayed Upgrade Clock